StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
RDGL

Vivos Inc.

RDGL OTC Surgical & Medical Instruments & Apparatus EDGAR ↗
$0.06
+0.00 +1.04%

Key statistics

from XBRL data in SEC filings
Market cap
$29.6M
Revenue (TTM)
$77.7K
Net income (TTM)
-$3.42M
EPS (TTM)
$-0.01
P/E ratio
Dividend yield
Free cash flow
-$2.16M
Cash
$3.27M
Total assets
$2.95M
Gross margin
-75.5%
52-week range
$0.04 – $0.14

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-03-31 May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K/A Entered a material agreement; Director or officer change Sep 24, 2025 8-K Entered a material agreement; Director or officer change Sep 22, 2025 8-K Other events Sep 18, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Other events Feb 10, 2025 8-K Unregistered sale of equity; Other events Feb 10, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Other events Jul 1, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Entered a material agreement; Director or officer change Mar 25, 2024 10-K Fiscal year ended 2023-12-31 Mar 18, 2024 8-K Unregistered sale of equity; Other events Dec 27, 2023 10-Q Quarter ended 2023-09-30 Nov 6, 2023 8-K Other events Oct 11, 2023 10-Q Quarter ended 2023-06-30 Aug 4, 2023 10-Q Quarter ended 2023-03-31 May 4, 2023 8-K Unregistered sale of equity; Other events May 2, 2023 10-K Fiscal year ended 2022-12-31 Mar 1, 2023 10-Q Quarter ended 2022-09-30 Oct 19, 2022 10-Q Quarter ended 2022-06-30 Jul 25, 2022 8-K Unregistered sale of equity; Other events Jul 11, 2022 10-Q Quarter ended 2022-03-31 May 10, 2022 10-K Fiscal year ended 2021-12-31 Mar 7, 2022 8-K Other events Jan 27, 2022 10-Q Quarter ended 2021-09-30 Oct 25, 2021 10-Q Quarter ended 2021-06-30 Aug 2, 2021 10-Q Quarter ended 2021-03-31 May 10, 2021 8-K Entered a material agreement; Director or officer change May 7, 2021 10-K Fiscal year ended 2020-12-31 Mar 24, 2021 8-K Took on a direct financial obligation; Unregistered sale of equity; Other events Dec 10, 2020 10-Q Quarter ended 2020-09-30 Nov 2, 2020 10-Q/A Quarter ended 2020-03-31 Aug 13, 2020 10-Q Quarter ended 2020-06-30 Aug 6, 2020 10-Q Quarter ended 2020-03-31 Jun 29, 2020